Wouters, Marjon
Ehlers, Lisa
Dzhus, Mariia
Kienapfel, Verena
Bucciol, Giorgia
Delafontaine, Selket
Hombrouck, Anneleen
Pillay, Bethany
Moens, Leen
Meyts, Isabelle
Funding for this research was provided by:
European Research Council (grant agreement No. 948959, grant agreement No. 948959, grant agreement No. 948959, grant agreement No. 948959, grant agreement No. 948959)
FWO Vlaanderen (11E0123N, G0B5120N, G0B5120N)
KU Leuven (C16/18/007, C16/18/007, C16/18/007, C16/18/007)
The Jeffrey Modell Foundation
Article History
Accepted: 26 June 2024
First Online: 6 July 2024
Declarations
:
: All reported studies/experiments involving human or animal subjects performed by the authors were in accordance with the ethical standards of institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Dr. Meyts reports grants and other from CSL-behring, other from Boehringer-Ingelheim, other from Takeda, grants and other from Octapharma, outside the submitted work; In addition, Dr. Meyts has a patent EP23201683.2 pending to KU Leuven.